Cláudia Miranda is an Assistant Doctoral Researcher at AccelBio.
Cláudia has 12 years of experience in stem cell engineering. As a researcher, she was involved in several projects, aiming at the expansion and neural induction of human pluripotent stem cells. Cláudia focused on the neurodevelopmental effects of different drugs, to pave the way to creating new platforms for the assessment of drug-induced toxicity during embryonic development. Overall, her research includes 36 different co-authors, collaborations with 2 biotech companies, and international universities, including Bönn University and Massachusetts Institute of Technology. Since 2020, she is focused on the generation of an advanced kidney organoid model for drug safety and toxicity screening.
Cláudia holds a Degree in Biochemistry from FCT NOVA Lisbon, a MSc in Biotechnology and a PhD in Biotechnology and Biosciences from Instituto Superior Técnico, University of Lisbon.